Obesity Paradox in the Course of Cerebrovascular Diseases

被引:13
|
作者
Brzecka, Anna [1 ]
Ejma, Maria [2 ]
机构
[1] Wroclaw Med Univ, Dept Pulmonol & Lung Canc, PL-53439 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Neurol, PL-53439 Wroclaw, Poland
来源
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE | 2015年 / 24卷 / 03期
关键词
obesity; obesity paradox; cerebrovascular diseases; cardiovascular diseases; preconditioning; BODY-MASS INDEX; SYSTOLIC HEART-FAILURE; POSSIBLE EXPLANATION; ISCHEMIC TOLERANCE; SLEEP-APNEA; MORTALITY; RISK; IMPACT; OVERWEIGHT; PROGNOSIS;
D O I
10.17219/acem/22287
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Obesity remains an important risk factor of cardiovascular and cerebrovascular diseases. However, it has been observed that increased body fat and body mass index predicted longer survival after the occurrence of a cardiovascular event. This observation has been named the obesity paradox. Initially, the term obesity paradox referred to the observation of the better outcome of cardiovascular diseases, such as heart failure and coronary heart disease, in obese patients as compared to underweight and normal-weight patients. Recently, similar, although fewer, observations confirm the occurrence of the obesity paradox in patients with acute cerebrovascular diseases. The underlying reasons for the protective effects of excessive body fat tissue against the consequences of acute cardiovascular and cerebrovascular diseases are poorly understood. The effect of preconditioning may be associated with the obesity paradox. The issue of the correlation between obesity and better survival of patients with cardiovascular and cerebrovascular diseases still remains largely unexplored. Debates for and against the obesity paradox continue
引用
收藏
页码:379 / 383
页数:5
相关论文
共 50 条
  • [1] Obesity and the "Obesity Paradox" in Cardiovascular Diseases
    Lavie, C. J.
    Milani, R. V.
    Ventura, H. O.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (01) : 23 - 25
  • [2] Updates on obesity and the obesity paradox in cardiovascular diseases
    Tutor, Austin W.
    Lavie, Carl J.
    Kachur, Sergey
    Milani, Richard, V
    Ventura, Hector O.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 78 : 2 - 10
  • [3] Life course explains the 'obesity paradox'?
    Strandberg, Timo E.
    Strandberg, Arto Y.
    EUROPEAN HEART JOURNAL, 2020, 41 (40) : 3963 - 3964
  • [4] Obesity: An Impact with Cardiovascular and Cerebrovascular Diseases
    Dutta, Savi
    Singhal, A. K.
    Suryan, Varsha
    Chandra, Nimai Chand
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2024, 39 (02) : 168 - 178
  • [5] Obesity: An Impact with Cardiovascular and Cerebrovascular Diseases
    Savi Dutta
    A. K. Singhal
    Varsha Suryan
    Nimai Chand Chandra
    Indian Journal of Clinical Biochemistry, 2024, 39 : 168 - 178
  • [6] An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases
    Elagizi, Andrew
    Kachur, Sergey
    Lavie, Carl J.
    Carbone, Salvatore
    Pandey, Ambarish
    Ortega, Francisco B.
    Milani, Richard V.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 61 (02) : 142 - 150
  • [7] INTRAPLATELET SEROTONIN CONCENTRATION IN COURSE OF CEREBROVASCULAR DISEASES
    KITA, E
    UTSUMI, M
    UMEGAKI, K
    ISHIMOTO, S
    HORIIKE, N
    KYOI, K
    UTSUMI, S
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 373 - 373
  • [8] The obesity paradox: Impact of obesity on the prevalence and prognosis of cardiovascular diseases
    Artham, Surya M.
    Lavie, Carl J.
    Milani, Richard V.
    Ventura, Hector O.
    POSTGRADUATE MEDICINE, 2008, 120 (02) : 34 - 41
  • [9] The Obesity Paradox: Impact of Obesity on the Prevalence and Prognosis of Cardiovascular Diseases
    Weir, Matthew R.
    POSTGRADUATE MEDICINE, 2009, 121 (01) : 164 - 165
  • [10] Obesity Paradox in Lung Diseases: What Explains It?
    Yao, Surui
    Zeng, Lei
    Wang, Fengyuan
    Chen, Kejie
    OBESITY FACTS, 2023, 16 (05) : 411 - 426